Delivery Order SPE2DB20D1100-SPE2DB24FA1P9
Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $23K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RESTASIS 0.05% eye emulsion. The $3,576.43 order, which has a completion date of December 29, 2023, is part of Amerisourcebergen Drug Corp's indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp, as a prime...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RESTASIS 0.05% eye emulsion. The $7,490.14 order is for delivery by January 24, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides pharmaceutical products and services to the Department of Defense. This order is part of...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $47,359.72 contract is for the supply of RESTASIS 0.05% eye emulsion to support military treatment programs and facilities. This order does not fall under any set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with...
- The Defense Logistics Agency (DLA) awarded a $1,080.48 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a large pharmaceutical distribution company. The contract is for the supply of RESTASIS 0.05% eye emulsion, a prescription medication. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. Under this single-award IDC,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $40,943.16 to Amerisourcebergen Drug Corp, the prime contractor, for the provision of RESTASIS 0.05% eye emulsion. This delivery order was issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- The Defense Logistics Agency (DLA) awarded a $2,384.16 delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RESTASIS 0.05% eye emulsion. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RESTASIS 0.05% eye emulsion. The $102,045.12 contract has a completion date of December 2, 2021 and does not use a set-aside designation. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceuticals, medical supplies, and distribution services to support DLA programs....
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $46,862.84 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. This contract is for the supply of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of June 9, 2022. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Restasis 0.05% eye emulsion in 60-unit quantities, with a ceiling value of $5,081.08 and an ultimate completion date of December 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $2,302.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RESTASIS 0.05% Eye Emulsion (30-count units) on December 1, 2025, with an ultimate completion date of December 2, 2025. This is a non-set-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...